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 Abstract 
Amaryllidaceae alkaloids (AAs) are a structurally diverse 
group of plant specialized metabolites with powerful 
biological activities. The medicinal properties of many AAs 
have been identified including the antitumor agent 
narciclasine and galanthamine, used for Alzheimer’s disease. 
Tracer studies have led to proposed pathways but AA 
biosynthesis remains molecularly uncharacterized. The use 
of systems biology-based approaches could lead to the 
unraveling of AA metabolic pathways. The elucidation of AA 
biosynthesis will provide necessary tools required to 
enhance AA production in plants as well as the development 
of microbial production platforms as an alternative to plants 
as a commercial source of valuable AAs. 
Keywords: amaryllidaceae alkaloid; plant secondary 
metabolism; galanthamine biosynthesis; natural products; 
systems biology. 
Abbreviations: AA, Amaryllidaceae alkaloid; 3,4-DHBA, 
3,4-dihydroxybenzaldehyde; PAL, phenylalanine ammonia 
lyase; Ca4H, cinnamate-4-hydroxylase; Ca3H, 
coumarate-3-hydroxylase; TYDC, tyrosine decarboxylase; 
CYP450, cytochromes P450. 
 
1. Introduction 
For centuries, a large number of plants have been used 
as essential resource for therapeutic agents against 
various human illnesses. Among these traditional sources 
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of medicines, the bulbous monocot Amaryllidaceae family, 
comprising over 1100 species, are among the top 20 of the 
most widely applied plant families (Jin, 2013). In addition 
to their pharmacological interests, the well-known 
horticultural ornamental value of Amaryllidaceae plants 
(Amaryllis, Narcissus and Galanthus), has long been 
recognized and exploited. 
The medicinal properties of the Amaryllidaceae are 
owed to the presence of specialized metabolites, the 
Amaryllidaceae alkaloids (AAs), which are specific to this 
plant family. To date, more than 500 structurally diverse 
AAs have been isolated (Jin, 2013) and modern 
phytochemical studies have shown the various 
pharmacological activities of numerous AAs. These include 
analgesic, anticancer, and antimicrobial activities (Bastida 
et al., 2011; Heinrich & Lee Teoh, 2004; Kornienko & 
Evidente, 2008; Nair & van Staden, 2013). For example, 
narciclasine displays potent antitumor activity (Kornienko 
& Evidente, 2008) whereas galanthamine, an 
acetylcholinesterase inhibitor, is used to treat symptoms of 
Alzheimer’s disease (Heinrich & Lee Teoh, 2004). As it is 
the case for many valuable plant natural products, the 
commercial use of most AAs is restricted by their limited 
availabilities due to their low concentrations in plants. For 
example, the yield of galanthamine from leaves of 
Leucojum aestivum is less than 0.2% DW and varies 
between 0.059-0.166% DW from plants of different 
geographical origin (Berkov, Bastida, Viladomat, & Codina, 
2011). Narciclasine levels are higher in Narcissus tazetta 
(65mg/kg) compared with other Amaryllidaceaea species 
such as L. aestivum (30mg/kg) and Galanthus nivalis 
(10mg/kg) however this yield is still too low for lucrative 
applications (Kornienko & Evidente, 2008). Currently, only 
galanthamine is used clinically and almost entirely 
produced from Leucojum and Narcissus cultivated plant 
species (Takos & Rook, 2013). Most AAs available 
commercially are obtained from their natural sources and 
only a few are produced synthetically. Although several 
chemical syntheses for galanthamine, narciclasine and 
others AAs have been described (Kornienko & Evidente, 
2008; Takos & Rook, 2013), chemists are still struggling to 
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devise a reasonably short synthetic pathway that can be 
used to produce these compounds on an economically 
viable commercial scale. Since most AAs display promising 
biological activities [but are produced in small quantities 
relative to the potential clinical and commercial demand], 
there are obvious interests in engineering AA production 
in plants or in heterologous expression systems. However, 
the lack of information on AA biosynthetic pathways, 
regulation and transport makes this task very challenging. 
To date, several AA pathways remain hypothetical and 
enzymes and metabolic intermediates await discovery. 
Recently, systems biology-based approaches have 
facilitated the discovery of biosynthetic genes involved in 
natural products metabolic pathways in other plant 
families through the integration of multiple ‘omics’ 
(genomic, transcriptomic, proteomic and metabolomic) 
datasets. This strategy appears to be a promising avenue 
for the elucidation of AA biosynthesis in order to identify 
and characterize biosynthetic enzymes. In the scope of this 
review, we are focusing on the molecular basis of AA 
biosynthesis and we will propose putative gene families 
involved in AA biosynthetic pathways. 
2. Biosynthesis 
In contrast to the extensive literature on the 
pharmaceutical effects of AAs, information on their 
molecular genetics and biochemical pathways is 
incomplete. Previous studies using radiolabeled 
precursors led to the biochemical elucidation of the first 
steps in AA biosynthesis (Barton & Cohen, 1957; Barton, 
Kirby, Taylor, & Thomas, 1963; Battersby, Fales, & 
Wildman, 1961; Eichhorn, Takada, Kita, & Zenk, 1998). 
Despite the vast structural diversity, AAs share a common 
central intermediate, norbelladine, which is formed 
through the condensation of aromatic amino acids 
derivatives; 3,4-dihydroxybenzaldehyde (3,4-DHBA also 
named protocatechuic aldehyde) and tyramine (Fig. 1). 
Interestingly, similarities to several plant specialized 
biosynthetic pathways can be observed. For example, the 
formation of 3,4-DHBA features the initial steps of the 
phenylpropanoid biosynthesis whereas the formation of 
the tyramine precursor is analogous to isoquinoline 
alkaloid biosynthesis. The resulting 
tetrahydroisoquinoline core of norbelladine is central to 
the biosynthesis of many structural types of AAs.  
2.1 Initial biosynthetic reactions 
The substrates and enzymes necessary for the first 
committed steps in plant specialized metabolism often 
appear to have been recruited from primary metabolic 
pathways (Chu, Wegel, & Osbourn, 2011). Substrates for 
the initial reactions of alkaloids biosynthesis are derived 
from primary metabolism, especially the aromatic amino 
acids L-phenylalanine and L-tyrosine. Additionally, since 
gene duplication is one of the most important components 
for the evolution of specialized metabolism, there are 
several “later” enzymes in these pathways that have 
ancestors in primary metabolism. For example, the 
enzyme homospermidine synthase, which catalyzes the 
first committed step to pyrrolizidine alkaloids, has most 
likely been developed by gene duplication from 
deoxyhypusin synthase, an enzyme from the polyamine 
biosynthetic pathway involved in cell division and growth 
(Moll et al., 2002). 
In the initial stages of AA biosynthesis, the enzyme 
phenylalanine ammonia lyase (PAL) catalyzes the 
elimination of ammonia to generate trans-cinnamic acid 
(Fig. 1). Two hydroxylation reactions catalyzed by 
cytochrome P450s, cinnamate-4-hydroxylase (Ca4H) and 
coumarate-3-hydroxylase (Ca3H) followed by the loss of 
two carbon atoms leads to the formation of the C6C1 
precursor, 3,4-DHBA (Bastida et al., 2011; Eichhorn et al., 
1998; Grisebach, 1973). These reactions are also part of 
phenylpropanoid metabolism, so that AA biosynthesis 
nicely shows the connections between two plant 
specialized pathways, alkaloid and phenylpropanoid. On 
the other hand, tyrosine is decarboxylated to tyramine by 
tyrosine decarboxylase (TYDC) (Bastida et al., 2011; 
Eichhorn et al., 1998; Grisebach, 1973; Takos & Rook, 
2013). TYDC is a unique and key regulatory enzyme in 
many alkaloid-producing plants. In addition to controlling 
the transition from primary to specialized metabolism, 
TYDC ensures an adequate supply of tyramine for the 
synthesis of various isoquinoline alkaloids including the 
well-known narcotic analgesics morphine and codeine 
(Desgagné-Penix & Facchini, 2011; Facchini, 2001; 
Facchini, Huber-Allanach, & Tari, 2000; Hagel & Facchini, 
2013; Ziegler & Facchini, 2008). Although the enzymatic 
reactions leading to the formation of AA precursors still 
need confirmation, feeding experiments in N. 
pseudonarcissus (Eichhorn et al., 1998) and recent 
transcriptome analyses of Lycoris aurea (Wang et al., 
2013) have proven the presence of metabolite 
intermediates and transcripts for PAL, C4H, C3H and 
TYDC. These findings support the current proposed 
pathways. However no gene sequences or enzymes have 
been isolated and characterized to date. 
2.2 Formation of the norbelladine skeleton 
All AAs are viewed as derivatives of the common 
skeleton structure of norbelladine (Fig. 1). The 
combination of 3,4-DHBA and tyramine results in the 
formation of a Schiff base intermediate which following 
reduction yields norbelladine (Dewick, 2009; Ghosal, 
Shanthy, & Singh, 1988). Several similar condensation 
reactions have been described in other plant alkaloid 
biosynthetic pathways. For example, the first committed 
step in the formation of benzylisoquinoline alkaloids (BIA) 
is the combination of two L-tyrosine derivatives 
(4-hydroxyphehylacetaldehyde and dopamine) by a 
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Pictet-Spengler condensation catalyzed by norcoclaurine 
synthase (NCS) to produce the 
trihydroxytetrahydroisoquinoline alkaloid norcoclaurine 
(Luk, Bunn, Liscombe, Facchini, & Tanner, 2007). NCS 
catalyzes a two-step reaction mechanism; a condensation 
reaction followed by an intramolecular cyclization (Luk et 
al., 2007). The electron-donating oxygen of the hydroxyl 
group of dopamine (missing in tyramine) is essential for 
the reaction to proceed and may provide a mechanistic 
explanation for the absence of cyclization in the 
condensation step of AA biosynthesis. Two different 
protein families (pathogenesis-related PR10-Betv1 and 
 
 
Fig. 1. Proposed AA biosynthetic pathway. Top: Early biosynthetic reactions leading to the norbelladine precursor (shaded 
gray). Middle: representation of the three backbone structures derived from the alternative phenol coupling reactions. 
Bottom: examples of chemical structures of AAs in each subgroups. Abbreviations defined in text. 
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2-oxoglutarate-dependent dioxygenase) have been 
reported to catalyze this reaction in vitro. However the 
PR10/Betv1-NCS was shown to be the major one involved 
in BIA biosynthesis in Papaver somniferum and Thalictrum 
flavum plants (Lee & Facchini, 2010; Minami, Dubouzet, 
Iwasa, & Sato, 2007; Samanani, Liscombe, & Facchini, 
2004). Another example of a Pictet-Spengler condensation 
is the combination of tryptamine and secologanin resulting 
in strictosidine, the general precursor of monoterpenoid 
indole alkaloids. In Rauvolfia serpentina, this reaction is 
catalyzed by strictosidine synthase, a member of the 
six-bladed four-stranded β-propeller fold protein family 
(Stockigt, Barleben, Panjikar, & Loris, 2008). 
The examples above show that the initial condensation 
reactions in alkaloid biosynthesis can be catalyzed by 
members of very different protein families. This suggests 
that the type of enzyme recruited for the non-cyclizing 
condensation reaction in AA biosynthesis may belong to 
one of these families. However, additional classes of 
enzymes should not be ruled out. 
It has been proposed that O-methylation of norbelladine 
precedes the oxidative phenol coupling, which yields the 
structurally diverse AAs. Plant O-methylation reactions are 
common transformation in the biosynthesis of alkaloids 
and are most often catalyzed by S-adenosyl-L-methionine 
(SAM)-dependent methyltransferases (MTs) (Liscombe, 
Louie, & Noel, 2012). Thus, it is assumed that norbelladine 
must be 4’-O-methylated to form 4’-O-methylnorbelladine. 
This compound then serves as the central intermediate 
from which multiple biosynthetic pathways lead to various 
structural types of AAs (Fig. 1). 
2.3 Phenol coupling reaction and formation of 
diverse AA subgroup backbones 
A crucial step in AA biosynthesis is the cyclization of 
4’-O-methylnorbelladine by oxidative C-C phenol coupling, 
which can occur in ortho-para, para-ortho and para-para 
positions. These alternative phenol coupling reactions 
generate three backbone structures. Accordingly, the 
different AA subgroups are referred to as ortho-para, 
para-ortho and para-para (Fig. 1). For example, antitumor 
AAs of the narciclasine-type are derived by a para-para 
phenol coupling step (Bastida et al., 2011; Kornienko & 
Evidente, 2008; Takos & Rook, 2013).  
Recently, several enzymes have been discovered in 
various alkaloids pathways, which catalyze oxidative C-C 
phenol coupling reactions. All these enzymes were found 
to be members of the plant cytochromes P450 (CYP450s) 
(Mizutani & Sato, 2011). CYP450s catalyze a wide variety 
of monooxygenation/hydroxylation reaction in specialized 
metabolism and some of them are involved in unusual 
reactions such as methylenedioxy-bridge formation, 
oxidative C-C bond cleavage, oxidative rearrangement of 
carbon skeletons and phenol coupling reactions. For 
example, the intramolecular C-C phenol coupling catalyzed 
by CYP80G2 participates in the formation of 
aporphine-type alkaloid in Coptis japonica (Ikezawa, 
Iwasa, & Sato, 2008). Substrate specificity studies of 
CYP80G2 revealed the promiscuity of this enzyme as it 
reacted with several derivatives of reticuline such as 
(R,S)-orientaline, (R,S)-codamine, (S)-N-methylcoclaurine, 
and (S)-coclaurine informing that it could accept different 
functional group on the C-ring. However, CYP80G2 did not 
react with derivatives whose functional group were 
different from reticuline on the A-ring suggesting that the 
A-ring plays an important role in substrate recognition 
(Ikezawa et al., 2008). Another example is salutaridine 
synthase, a member of the CYP719B1, which catalyzes the 
para-ortho coupling of reticuline in the biosynthesis of 
morphinan alkaloids in P. somniferum. CYP719B1 is highly 
stereospecific as it catalyzes the C-C phenol coupling of 
only (R)-reticuline resulting in formation of salutaridine 
(Gesell et al., 2009). These examples demonstrate that 
specific CYP450s are able to catalyze intramolecular C-C 
phenol coupling reactions in alkaloid biosynthesis and that 
members of two CYP450 families, CYP80 and CYP719, 
have been identified. A recent comparative analysis of 
plant CYP450 sequences has shown that only the CYP80 
family occurs in monocot plant although no 
Amaryllidaceae species were represented (Nelson & 
Werck-Reichhart, 2011). The CYP80 family has been 
associated with phenolic coupling reactions in several 
species whereas CYP719s are restricted to Ranunculales 
plants including P. somniferum and C. japonica. In addition, 
the latter steps of AA biosynthesis involve multiple C-C and 
C-O bond creation including methyledioxy-bridge 
formation. In other alkaloid pathways such as the BIA, 
these reactions are catalyzed by CYP719s and CYP80s 
(Diaz Chavez, Rolf, Gesell, & Kutchan, 2011; Gesell et al., 
2009; Ikezawa et al., 2008). Altogether, these studies 
suggest that the phenol coupling and the 
methyledioxy-bridge formation steps in AA biosynthesis 
are likely to involve CYP450 of the CYP80 family. However, 
additional families of enzymes should not be ruled out. 
Interestingly, AAs from all three subgroups of phenol 
coupling can co-occur in a single plant, whereas some 
species and cultivars contains only one subgroup of AA 
(Berkov, Martinez-Frances, Bastida, Codina, & Rios, 2014; 
Kornienko & Evidente, 2008), This further suggests the 
existence of several CYP450 genes with different substrate, 
and product specificity with respect to the positions of 
intramolecular oxidative C-C phenol coupling. 
2.4 Core backbone structure modifications and 
decorations 
The three backbone structures obtained from the phenol 
coupling steps form the scaffolds of further alkaloid 
diversity leading to more than 500 AAs known to date (Jin, 
2013). For example, in BIA biosynthesis, the reticuline 
Plant Science Today (2014) 1(3): 114-120 
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skeleton is a basic building block for several types of 
isoquinoline alkaloids divided in several categories 
including aporphines, benzophenanthridines, 
protoberberines and morphinans (Desgagné-Penix & 
Facchini, 2011). A complex network of enzymatic reactions 
will produce a spectrum of compounds that accumulate 
species-, cultivar-, tissue-, and development-specific. These 
chemical modifications are achieved by a multitude of 
enzymes catalyzing various types of reactions, such as O- 
and N-methylations (OMTs, NMTs), C-C and C-O bond 
formations, oxidations and reductions, demethylations, 
and hydroxylations resulting in a variety of different 
structures. Fig. 1 shows an example for each phenol 
coupling subgroup of AA. The numerous AA pathways for 
which the complete set of reactions and biosynthetic genes 
have not yet been compiled and remain a significant 
challenge. However, phylogenetic analyses with candidates 
of analogous alkaloid pathways, such as the isoquinoline 
alkaloids, appear to be a logical and promising strategy. 
3. Systems Biology and future directions 
Until recently, non-model organisms such as medicinal 
plants were recalcitrant to modern molecular biology 
approaches for gene and pathway discovery due to the 
lack of genomic information and experimental protocols. 
However, the recent advances in ‘omics’ platforms and 
systems biology have revolutionized our understanding of 
natural products metabolism in non-model species 
(Schilmiller, Pichersky, & Last, 2012; Xiao et al., 2013) and 
correlations between plant transcriptome, proteome and 
metabolome have been successfully used for the 
identification of novel genes involved in alkaloid 
biosynthesis (Desgagne-Penix & Facchini, 2012; 
Desgagne-Penix, Farrow, Cram, Nowak, & Facchini, 2012; 
Desgagne-Penix et al., 2010; Liscombe, Ziegler, Schmidt, 
Ammer, & Facchini, 2009; Ziegler, Diaz-Chavez, Kramell, 
Ammer, & Kutchan, 2005; Ziegler et al., 2006). Each 
Amaryllidaceae species studied to date displays a specific 
AA profile, often with a few dominant compounds and a 
larger number of compounds at lower concentrations 
(Bastida et al., 2011; Berkov et al., 2014; Kornienko & 
Evidente, 2008). Although the molecular origin of this 
chemical diversity has not yet been clarified, these profiles 
likely result from differences in the expression level and 
substrate specificity of the various biosynthetic enzymes. 
The development and subsequent integration of ‘omics’ 
databases for Amaryllidaceae plants displaying different 
AA profiles would allow for the identification of candidate 
genes involved in AA biosynthesis. For example, searches 
by sequence similarity to Arabidopsis, orthologous genes 
involved in synthesis of the precursors 3,4-DHBA and 
tyramine, e.g. PAL, Ca4H, Ca3H and TYDC, can be identified. 
Those could be targeted for silencing or over-expression in 
plants to assess their role(s) in AA biosynthesis. Recently, 
the transcriptome of the Amaryllidaceae Lycoris aurea was 
sequenced and assembled and putative genes involved in 
AAs biosynthesis (PAL, TYDC, OMT, NMT, P450) were 
identified based on sequence analysis (Wang et al., 2013) 
however none of the biosynthetic enzymes involved in 
these pathways have been isolated or functionally 
characterized. 
4. Conclusions 
Over the past several years, extensive phytochemical 
and pharmacological analyses have reported the 
numerous biological activities of Amaryllidaceae alkaloids 
and numerous AAs display interesting and valuable 
pharmacological capabilities. Earlier biochemical tracer 
studies have led to the current AA biosynthetic proposed 
pathways. However the molecular identity of the 
biosynthetic enzymes remains unknown. The 
technological advances brought as part of the 
post-genomics era have revolutionized the study of 
alkaloid metabolism and discoveries made over the past 
years have relied largely on ‘omics’ tools including 
transcriptome libraries, proteomic analyses and 
metabolomics methods. Integration of these ‘omics’ 
resources such as comparative analyses of metabolite and 
transcript data from Amaryllidaceae species will lead to 
the identification and isolation of numerous enzymes 
involved in AA biosynthesis. A deeper understanding of the 
molecular mechanisms involved in AA biosynthesis will 
support breeding efforts to produced cultivars of 
Amaryllidaceae species with enhanced AA production. In 
addition, it will pave the way for the successful metabolic 
engineering of microbial systems for the production of 
valuable AAs.  
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